Locally advanced or metastatic solid tumors with oncogene amplifications
BOLDBoundless Bio IncCatalyst overview
Research summary
This catalyst tracks a Failed discontinued for BBI-355 + BBI-825 in Locally advanced or metastatic solid tumors with oncogene amplifications. The expected timing is based on the latest available company guidance and may change.
POTENTIATE trial. 8/5/25- Enrollment ongoing. 11/05/25:- Combo arm actively enrolling; initial proof-of-concept data expected by H1 2028. 03/09/26:- Enrollment in Ph1/2 POTENTIATE trial ceased; future data timelines uncertain, program deprioritized.
Verification
Confirm timing and program details against the company announcement or filing.